Found: 9
Select item for more details and to access through your institution.
Safety of vemurafenib in patients with BRAF mutated metastatic melanoma: the Spanish experience.
- Published in:
- Clinical & Translational Oncology, 2016, v. 18, n. 11, p. 1147, doi. 10.1007/s12094-016-1498-9
- By:
- Publication type:
- Article
Clinical use of ipilimumab for metastatic melanoma in Spain: towards a more consistent approach.
- Published in:
- Clinical & Translational Oncology, 2016, v. 18, n. 10, p. 1044, doi. 10.1007/s12094-016-1484-2
- By:
- Publication type:
- Article
MYH polyposis syndrome: clinical findings, genetics issues and management.
- Published in:
- Clinical & Translational Oncology, 2014, v. 16, n. 8, p. 675, doi. 10.1007/s12094-014-1171-0
- By:
- Publication type:
- Article
Preliminary Results of the Combination of Bevacizumab and Weekly Paclitaxel in Advanced Melanoma.
- Published in:
- Oncology, 2008, v. 74, n. 1/2, p. 12, doi. 10.1159/000138351
- By:
- Publication type:
- Article
Multiple cycles of dose-intensive chemotherapy with repeated stem cell support as induction treatment in metastatic breast cancer: a feasibility study.
- Published in:
- Bone Marrow Transplantation, 2001, v. 28, n. 3, p. 235, doi. 10.1038/sj.bmt.1703125
- By:
- Publication type:
- Article
Pulmonary embolism after local urokinase instillation in a Hickman catheter.
- Published in:
- Bone Marrow Transplantation, 2001, v. 28, n. 1, p. 112, doi. 10.1038/sj.bmt.1703091
- By:
- Publication type:
- Article
ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours.
- Published in:
- British Journal of Cancer, 2004, v. 90, n. 5, p. 1047, doi. 10.1038/sj.bjc.6601644
- By:
- Publication type:
- Article
Guidelines for biomarker testing in metastatic melanoma: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
- Published in:
- Clinical & Translational Oncology, 2014, v. 16, n. 4, p. 362, doi. 10.1007/s12094-013-1090-5
- By:
- Publication type:
- Article
Response of resistant melanoma to a combination of weekly paclitaxel and bevacizumab.
- Published in:
- Clinical & Translational Oncology, 2007, v. 9, n. 2, p. 119, doi. 10.1007/s12094-007-0023-6
- By:
- Publication type:
- Article